Helpful Links & Resources
Reading Time: 6 mins
Published On: August 26, 2024
Katie Duquette - editor
Katie Duquette, Esquire, edits our legal and medical content. She works as a clinical research coordinator in neurology at Thomas Jefferson University and received her law degree in 2016 from Villanova University School of Law. She is a licensed attorney in the District of Columbia.
More to Read
August 28, 2024
FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma
>READ
August 27, 2024
J&J’s Talc Legal Battles: Medical Monitoring and Settlement
>READ
August 24, 2024
Talc Settlement Disputes Keep Doors Open for Future Claims Against J&J
>READ
August 22, 2024
GAG-DP Biomaterial Advances Mesothelioma Research
>READ
August 21, 2024
$59.7M Transfer Triggers Legal Battle Over Asbestos Claims
>READ
August 18, 2024
Pleural and Peritoneal Mesothelioma Found in Female Patient
>READ
News & Data
FILTER:
Rachel Sasser
3 mins read - September 18, 2024
A jury awarded over $39 million to a Utah couple in a landmark mesothelioma case involving the use of asbestos-contaminated talc in a surgical procedure. The plaintiffs, Bryce and...
Matthew Davis
3 mins read - September 11, 2024
On September 4, Johnson & Johnson boldly announced a $1.1 billion increase to its proposed talc settlement, This would increase the settlement to more than $9 billion paid...
Matthew Davis
3 mins read - September 10, 2024
Johnson & Johnson is planning to pay an additional $1.1 billion in its proposed settlement to clear up tens of thousands of lawsuits alleging the company, and its baby powder...
Amna Anees
5 mins read - August 28, 2024
In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance to Insilico Medicine’s ISM6331, a potential...
Melissa Bill
5 mins read - August 27, 2024
The consumer products behemoth Johnson & Johnson is now submerged under a barrage of lawsuits accusing the company’s talc-based products of being the root cause of their...
Matthew Davis
4 mins read - August 24, 2024
The complex negotiations surrounding Johnson & Johnson’s $6.5 billion attempt to settle thousands of lawsuits regarding its talc products have hit a stumbling block,...
August 22, 2024
GAG-DP Biomaterial Advances Mesothelioma Research
>READ
August 21, 2024
$59.7M Transfer Triggers Legal Battle Over Asbestos Claims
>READ
August 18, 2024
Pleural and Peritoneal Mesothelioma Found in Female Patient
>READ
August 17, 2024
Study Finds State-Level Trends and Asbestos-Talc Risks
>READ
August 16, 2024
What The J&J $63.4M Talc Lung Cancer Verdict Means for You
>READ
August 16, 2024
The End of Asbestos: EPA’s Historic Ban and Its Implications
>READ
August 16, 2024
Talc Lung Cancer Lawsuit Costs Johnson & Johnson $63.4 Million
>READ
August 15, 2024
PET/CT Enhancing Diagnosis and Treatment of Pleural Mesothelioma
>READ
August 14, 2024
Secondary Exposure Emerges as a Hidden Threat in the Ongoing Asbestos Crisis
>READ
Browse Categories
Copyright © 2024 by Mesowatch. All Rights Reserved.
The information on this website is proprietary and protected by law. It is not, nor should it be taken as medical or legal advice. None of the content on this site is intended to substitute for professional medical advice, diagnosis, treatment, or legal counsel. Any unauthorized use, copying, or dissemination will be prosecuted to the fullest extent of the law. Please read our disclaimer for more details.